Wednesday, May 4, 2011

Crown Biosciences Scores $28.8M

Santa Clara-based Crown Biosciences, a provider of clinical testing services for the oncology pharmaceuticals development market, said this mornign that it has raised $28.8M in a Series C financing round. The roun was led by OrbiMed Advisors Caduceus Asia Partners Fund, Argonaut Private Equity, the CID Group, IBT, and CDIB Capital Investment. The round also included prior investors Qiming Venture Partners and CRCI. The firm said the firm will go towards expanding its services. More information »